Biotechnology COVID-19, Social Movements, and Health Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Vaccines
eu
-
-
Biotechnology Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Timo Minssen VaccinesThe Prospects for an IP Waiver Under the TRIPS Agreement
Read more: The Prospects for an IP Waiver Under the TRIPS Agreement -
Carmel Shachar Digital Health Events Featured Health Law Policy I. Glenn Cohen International Mobile Health Petrie-Flom Center Privacy Public Health Race VaccinesKey Takeaways from Petrie-Flom Center Discussion on Vaccine Passports
Read more: Key Takeaways from Petrie-Flom Center Discussion on Vaccine Passports -
Artificial Intelligence Bioethics FDA Featured Health Information Technology Health Law Policy Race Resource Allocation Social Determinants of HealthTop Health Considerations in the European Commission’s ‘Harmonised Rules on Artificial Intelligence’
Read more: Top Health Considerations in the European Commission’s ‘Harmonised Rules on Artificial Intelligence’ -
Carmel Shachar Chloe Reichel Digital Health Featured Health Information Technology Health Law Policy International Mobile Health Privacy Public Health Vaccines
Fake Vaccine Cards and the Challenges of Decentralized Health Data
Read more: Fake Vaccine Cards and the Challenges of Decentralized Health Data -
Are COVID Certificates the Answer to Safe EU Travel During the Pandemic?
Read more: Are COVID Certificates the Answer to Safe EU Travel During the Pandemic?